Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by product type
1.4.2. Market size breakdown, by application
1.4.3. Market size breakdown, by end use
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Product Type (2017–2030)
7.3. Market Revenue, by Application (2017–2030)
7.4. Market Revenue, by End Use (2017–2030)
7.5. Market Revenue, by Region (2017–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Product Type (2017–2030)
8.3. Market Revenue, by Application (2017–2030)
8.4. Market Revenue, by End Use (2017–2030)
8.5. Market Revenue, by Country (2017–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Product Type (2017–2030)
9.3. Market Revenue, by Application (2017–2030)
9.4. Market Revenue, by End Use (2017–2030)
9.5. Market Revenue, by Country (2017–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Product Type (2017–2030)
10.3. Market Revenue, by Application (2017–2030)
10.4. Market Revenue, by End Use (2017–2030)
10.5. Market Revenue, by Country (2017–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Product Type (2017–2030)
11.3. Market Revenue, by Application (2017–2030)
11.4. Market Revenue, by End Use (2017–2030)
11.5. Market Revenue, by Country (2017–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Product Type (2017–2030)
12.3. Market Revenue, by Application (2017–2030)
12.4. Market Revenue, by End Use (2017–2030)
12.5. Market Revenue, by Country (2017–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Product Type (2017–2030)
13.3. Market Revenue, by Application (2017–2030)
13.4. Market Revenue, by End Use (2017–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Product Type (2017–2030)
14.3. Market Revenue, by Application (2017–2030)
14.4. Market Revenue, by End Use (2017–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Product Type (2017–2030)
15.3. Market Revenue, by Application (2017–2030)
15.4. Market Revenue, by End Use (2017–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Product Type (2017–2030)
16.3. Market Revenue, by Application (2017–2030)
16.4. Market Revenue, by End Use (2017–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Product Type (2017–2030)
17.3. Market Revenue, by Application (2017–2030)
17.4. Market Revenue, by End Use (2017–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Product Type (2017–2030)
18.3. Market Revenue, by Application (2017–2030)
18.4. Market Revenue, by End Use (2017–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Product Type (2017–2030)
19.3. Market Revenue, by Application (2017–2030)
19.4. Market Revenue, by End Use (2017–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Product Type (2017–2030)
20.3. Market Revenue, by Application (2017–2030)
20.4. Market Revenue, by End Use (2017–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Product Type (2017–2030)
21.3. Market Revenue, by Application (2017–2030)
21.4. Market Revenue, by End Use (2017–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Product Type (2017–2030)
22.3. Market Revenue, by Application (2017–2030)
22.4. Market Revenue, by End Use (2017–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Product Type (2017–2030)
23.3. Market Revenue, by Application (2017–2030)
23.4. Market Revenue, by End Use (2017–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Product Type (2017–2030)
24.3. Market Revenue, by Application (2017–2030)
24.4. Market Revenue, by End Use (2017–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Product Type (2017–2030)
25.3. Market Revenue, by Application (2017–2030)
25.4. Market Revenue, by End Use (2017–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Product Type (2017–2030)
26.3. Market Revenue, by Application (2017–2030)
26.4. Market Revenue, by End Use (2017–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Product Type (2017–2030)
27.3. Market Revenue, by Application (2017–2030)
27.4. Market Revenue, by End Use (2017–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Product Type (2017–2030)
28.3. Market Revenue, by Application (2017–2030)
28.4. Market Revenue, by End Use (2017–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Product Type (2017–2030)
29.3. Market Revenue, by Application (2017–2030)
29.4. Market Revenue, by End Use (2017–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. BASF SE
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. Koninklijke DSM N.V.
31.2.1. Business overview
31.2.2. Product and service offerings
31.2.3. Key financial summary
31.3. Herbalife Nutrition Ltd.
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. Amway Corporation
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. Prenetics Limited
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. Nutrigenomix Inc.
31.6.1. Business overview
31.6.2. Product and service offerings
31.7. Viome Life Sciences Inc.
31.7.1. Business overview
31.7.2. Product and service offerings
31.8. Habit LLC
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. Atlas Biomed Group Limited
31.9.1. Business overview
31.9.2. Product and service offerings
31.10. Abbott
31.10.1. Business overview
31.10.2. Product and service offerings
31.10.3. Key financial summary
31.11. Superior Supplement Manufacturing
31.11.1. Business overview
31.11.2. Product and service offerings
31.12. GX Sciences LLC
31.12.1. Business overview
31.12.2. Product and service offerings
31.13. Nutralliance
31.13.1. Business overview
31.13.2. Product and service offerings
31.14. Helix OpCo LLC
31.14.1. Business overview
31.14.2. Product and service offerings
31.15. Baze Labs Inc.
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
| ※参考情報 個別化栄養とは、個々の人々の生理的特性、遺伝的背景、ライフスタイル、健康状態に基づいて、食事や栄養の摂取方法を最適化するアプローチを指します。この考え方は、一般的な栄養ガイドラインがすべての人に当てはまらないことを踏まえており、特に個々のニーズに応じた摂取が健康を維持・改善する上で重要であると認識されています。 個別化栄養にはいくつかの種類があります。まず、遺伝子解析に基づくアプローチです。個々の遺伝子情報をもとに、どの栄養素が不足しやすいか、または過剰摂取の影響を受けやすいかを分析し、その結果に基づいて食事プランを設計します。次に、健康状態に基づく個別化があります。例えば、糖尿病や心臓病などの特定の疾患を持っている人は、その病気に特有の栄養管理が必要となります。また、アスリートや特定の身体活動を行っている人に対しては、パフォーマンスを向上させるための特別な栄養ガイドラインが必要です。 さらに、ライフスタイルに基づいた個別化栄養もあります。食事の選び方や食べる時間、運動習慣、ストレスレベルなど、日常生活の要因によっても必要な栄養素は変わります。このような観点から、個別化栄養は個々のライフスタイルに適応する形で構築されることが求められます。 個別化栄養の用途は多岐にわたります。まず、健康の維持や疾病予防のために広く活用されています。たとえば、慢性疾患を持つ人が特定の栄養素を補うことで症状を改善したり、新たな疾患のリスクを減少させたりすることが期待されています。また、ダイエットや体重管理の領域でも、個別のニーズに応じたプランを立てることで、より効果的な結果を得られることがあります。さらに、パフォーマンス向上を目指すアスリートに対しては、体の状態や運動量に応じた栄養摂取の提案が行われており、これによりトレーニング効果を最大限に引き出すことが可能です。 関連技術としては、遺伝子解析技術やデジタルヘルス技術が挙げられます。遺伝子解析技術は、個々の遺伝子情報を解析することで、特定の栄養素に対する感受性や必要量を明らかにします。これにより、個別の食事プランを提供するための科学的根拠を得ることができます。 デジタルヘルス技術は、スマートフォンアプリやウェアラブルデバイスを通じて、個々の食事や活動データを収集し、分析します。このデータを基に、栄養の摂取状況をリアルタイムでモニタリングし、必要に応じて食事のアドバイスを提供することが可能です。技術の進化により、個人が自分自身の健康や栄養状態を常に把握しやすくなっており、これが個別化栄養の普及を後押ししています。 このように、個別化栄養は今後の健康管理や栄養摂取の重要な手法として注目を集めています。特に、科学的研究や技術の進展によって、より多くの人々が自分に合った栄養摂取方法を見つけ出し、健康的な生活を送るための手助けが期待されています。個々のニーズに応じたアプローチがますます重要視される今、私たちの生活における栄養の考え方が大きく変わっていくことでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

